300 related articles for article (PubMed ID: 24283771)
1. Third-party tolerogenic dendritic cells reduce allo-reactivity in vitro and ameliorate the severity of acute graft-versus-host disease in allo-bone marrow transplantation.
Yang J; Li R; Ren Y; Yang Y; Xie R; Fan H
Scand J Immunol; 2013 Dec; 78(6):486-96. PubMed ID: 24283771
[TBL] [Abstract][Full Text] [Related]
2. [The role of third-party tolerogenic dendritic cells in the prevention of acute graft-versus-host-disease following allogeneic bone marrow transplantation in mice].
Li GP; Yang J; Hao J; Yang YM; Ren YN; Xie RF; Fan HH; Qian KC
Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):461-6. PubMed ID: 22967381
[TBL] [Abstract][Full Text] [Related]
3. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
[TBL] [Abstract][Full Text] [Related]
4. Recipient-Derived Allo-iTregs Induced by Donor DCs Effectively Inhibit the Proliferation of Donor T Cells and Reduce GVHD.
Yang ZG; Wen RT; Feng JS; Cao PJ; Zhou HT; Liu WX
Anat Rec (Hoboken); 2019 May; 302(5):825-836. PubMed ID: 30312018
[TBL] [Abstract][Full Text] [Related]
5. [Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].
Wang SH; Li DP; Zhang YJ; Zhang P; Zeng LY; Pan XY; Xu KL; Huang YH
Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):88-93. PubMed ID: 22730654
[TBL] [Abstract][Full Text] [Related]
6. [Influence of mouse genetic engineering regulatory T cells infusion on post-allogeneic bone marrow transplantation acute graft-versus-host disease in mice].
Cao J; Li L; Chen C; Zeng LY; Li ZY; Pan XY; Xu KL
Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):83-8. PubMed ID: 21429372
[TBL] [Abstract][Full Text] [Related]
7. Prevention of murine acute graft-versus-host disease by recipient-derived TGFbeta1-treated dendritic cells.
Mou HB; Lin MF; Cen H; Huang H; Cai Z
Transplant Proc; 2004 Jun; 36(5):1604-6. PubMed ID: 15251394
[TBL] [Abstract][Full Text] [Related]
8. Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells.
Torres-Aguilar H; Aguilar-Ruiz SR; González-Pérez G; Munguía R; Bajaña S; Meraz-Ríos MA; Sánchez-Torres C
J Immunol; 2010 Feb; 184(4):1765-75. PubMed ID: 20083662
[TBL] [Abstract][Full Text] [Related]
9. Induced regulatory T cells promote tolerance when stabilized by rapamycin and IL-2 in vivo.
Zhang P; Tey SK; Koyama M; Kuns RD; Olver SD; Lineburg KE; Lor M; Teal BE; Raffelt NC; Raju J; Leveque L; Markey KA; Varelias A; Clouston AD; Lane SW; MacDonald KP; Hill GR
J Immunol; 2013 Nov; 191(10):5291-303. PubMed ID: 24123683
[TBL] [Abstract][Full Text] [Related]
10. A mouse model of adoptive immunotherapeutic targeting of autoimmune arthritis using allo-tolerogenic dendritic cells.
Yang J; Yang Y; Ren Y; Xie R; Zou H; Fan H
PLoS One; 2013; 8(10):e77729. PubMed ID: 24204938
[TBL] [Abstract][Full Text] [Related]
11. Tolerogenic dendritic cells suppress murine corneal allograft rejection by modulating CD28/CTLA-4 expression on regulatory T cells.
Yan F; Cai L; Hui Y; Chen S; Meng H; Huang Z
Cell Biol Int; 2014 Jul; 38(7):835-48. PubMed ID: 24604878
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic expansion of donor-derived, naturally occurring CD4(+)Foxp3(+) regulatory T cells reduces acute graft-versus-host disease lethality without abrogating the graft-versus-leukemia effect in murine models.
Duramad O; Laysang A; Li J; Ishii Y; Namikawa R
Biol Blood Marrow Transplant; 2011 Aug; 17(8):1154-68. PubMed ID: 21145405
[TBL] [Abstract][Full Text] [Related]
13. B7.2-/- mature dendritic cells generate T-helper 2 and regulatory T donor cells in fetal mice after in utero allogeneic bone marrow transplantation.
Bhattacharyya S; Cowan MJ
Biol Blood Marrow Transplant; 2005 Sep; 11(9):657-71. PubMed ID: 16125636
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta (TGFβ) plays a crucial role in prolonging allograft survival in an allodepletion ("pruning") skin transplant model.
Watson D; Zhang GY; Hu M; Wang YM; Fletcher J; Sartor M; Alexander SI
Transpl Immunol; 2014 May; 30(4):168-77. PubMed ID: 24746800
[TBL] [Abstract][Full Text] [Related]
15. Tolerogenic dendritic cells modified by tacrolimus suppress CD4(+) T-cell proliferation and inhibit collagen-induced arthritis in mice.
Ren Y; Yang Y; Yang J; Xie R; Fan H
Int Immunopharmacol; 2014 Jul; 21(1):247-54. PubMed ID: 24836681
[TBL] [Abstract][Full Text] [Related]
16. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival.
Wang H; Ge W; Arp J; Zassoko R; Liu W; Ichim TE; Jiang J; Jevnikar AM; Garcia B
J Immunol; 2009 May; 182(10):5970-81. PubMed ID: 19414748
[TBL] [Abstract][Full Text] [Related]
17. In vitro-expanded CD4(+)CD25(high)Foxp3(+) regulatory T cells controls corneal allograft rejection.
Guo X; Jie Y; Ren D; Zeng H; Zhang Y; He Y; Pan Z
Hum Immunol; 2012 Nov; 73(11):1061-7. PubMed ID: 22939904
[TBL] [Abstract][Full Text] [Related]
18. IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect.
Couturier M; Lamarthée B; Arbez J; Renauld JC; Bossard C; Malard F; Bonnefoy F; Mohty M; Perruche S; Tiberghien P; Saas P; Gaugler B
Leukemia; 2013 Jul; 27(7):1527-37. PubMed ID: 23399894
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.
Zeng M; Guinet E; Nouri-Shirazi M
Transpl Immunol; 2009 Dec; 22(1-2):82-92. PubMed ID: 19635560
[TBL] [Abstract][Full Text] [Related]
20. Intravenous apoptotic spleen cell infusion induces a TGF-beta-dependent regulatory T-cell expansion.
Kleinclauss F; Perruche S; Masson E; de Carvalho Bittencourt M; Biichle S; Remy-Martin JP; Ferrand C; Martin M; Bittard H; Chalopin JM; Seilles E; Tiberghien P; Saas P
Cell Death Differ; 2006 Jan; 13(1):41-52. PubMed ID: 15962005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
